| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 215.42M | 223.47M | 233.67M | 244.39M | 218.62M | 188.16M |
| Gross Profit | 61.87M | 63.35M | 58.83M | 61.93M | 58.43M | 49.91M |
| EBITDA | 17.75M | 18.57M | 14.58M | 9.26M | 18.89M | 15.84M |
| Net Income | 1.16M | 1.04M | -4.44M | -2.87M | 8.98M | 5.79M |
Balance Sheet | ||||||
| Total Assets | 231.99M | 229.00M | 230.16M | 265.33M | 255.02M | 209.92M |
| Cash, Cash Equivalents and Short-Term Investments | 29.11M | 24.26M | 20.88M | 31.80M | 26.74M | 30.27M |
| Total Debt | 85.08M | 62.95M | 60.27M | 85.64M | 64.22M | 29.76M |
| Total Liabilities | 109.33M | 107.92M | 105.98M | 129.44M | 115.87M | 78.11M |
| Stockholders Equity | 122.66M | 121.08M | 124.18M | 135.89M | 139.15M | 131.80M |
Cash Flow | ||||||
| Free Cash Flow | 7.70M | 13.47M | 24.00M | -2.66M | -23.14M | 20.24M |
| Operating Cash Flow | 13.42M | 16.89M | 28.58M | 2.96M | -17.90M | 23.30M |
| Investing Cash Flow | -5.62M | -2.21M | -235.00K | -5.46M | -11.03M | -2.98M |
| Financing Cash Flow | -2.04M | -10.87M | -38.17M | 7.36M | 24.06M | -17.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.68B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
71 Outperform | £893.64M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
70 Neutral | £43.02M | 10.36 | 11.64% | 7.35% | -25.56% | -42.49% | |
65 Neutral | £100.43M | 7.63 | 3.83% | 6.69% | -13.30% | -60.03% | |
65 Neutral | £1.17B | 27.39 | 7.31% | 1.06% | -13.81% | 13.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £80.91M | 17.57 | 0.95% | 2.61% | -6.32% | ― |